GGrantIndex
← Leaderboards

Paula Riggs

University Of Colorado Denver

$36,042,072
Attributed
$37,882,885
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$37,882,885 · 6

By mechanism

K12$16,936,631 · 1
U10$10,507,848 · 1
R01$9,522,416 · 3
P50$915,990 · 1

Top collaborators

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Addiction

Research focus

AddictionDrug AbuseAdolescentMental HealthSubstance Use DisorderComorbidityAreaNational Institute Of Drug AbuseSubstance Abuse ProblemYouthFundingClinical ResearchClinical Trials NetworkHuman Therapy EvaluationHuman SubjectClinical TrialsCommunitiesChildhoodCareerReportingAdolescenceResearch PersonnelAwardParticipant

Grant awards (44)

Evaluation of Clinical Effectiveness, Cost, and Implementation Factors to Optimize Scalability of Treatment for Co-Occurring SUD and PTSD Among Teens$726,104
R01 · FY2025 · DA
Pilot Project Core$457,995
P50 · FY2025 · DA · contact PI
Evaluation of Clinical Effectiveness, Cost, and Implementation Factors to Optimize Scalability of Treatment for Co-Occurring SUD and PTSD Among Teens$728,434
R01 · FY2024 · DA
Pilot Project Core$457,995
P50 · FY2024 · DA · contact PI
Evaluation of Clinical Effectiveness, Cost, and Implementation Factors to Optimize Scalability of Treatment for Co-Occurring SUD and PTSD Among Teens$730,020
R01 · FY2023 · DA
Evaluation of Clinical Effectiveness, Cost, and Implementation Factors to Optimize Scalability of Treatment for Co-Occurring SUD and PTSD Among Teens$731,580
R01 · FY2022 · DA
Evaluation of Clinical Effectiveness, Cost, and Implementation Factors to Optimize Scalability of Treatment for Co-Occurring SUD and PTSD Among Teens$765,488
R01 · FY2021 · DA
AACAP Physician Scientist Program in Substance Abuse$1,328,986
K12 · FY2019 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,328,986
K12 · FY2018 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,328,986
K12 · FY2017 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,249,488
K12 · FY2016 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,275,966
K12 · FY2015 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,253,134
K12 · FY2013 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,252,077
K12 · FY2012 · DA · contact PI
Bupropion for ADHD in Adolescents with Substance Use Disorders$585,641
R01 · FY2012 · DA · contact PI
Bupropion for ADHD in Adolescents with Substance Use Disorders$542,986
R01 · FY2011 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$459,943
K12 · FY2011 · DA · contact PI
Bupropion for ADHD in Adolescents with Substance Use Disorders$122,581
R01 · FY2011 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,248,633
K12 · FY2010 · DA · contact PI
Bupropion for ADHD in Adolescents with Substance Use Disorders$559,443
R01 · FY2010 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,248,747
K12 · FY2009 · DA · contact PI
Bupropion for ADHD in Adolescents with Substance Use Disorders$566,601
R01 · FY2009 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,133,676
K12 · FY2008 · DA · contact PI
Bupropion for ADHD in Adolescents with Substance Use Disorders$568,107
R01 · FY2008 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,133,676
K12 · FY2007 · DA · contact PI
AACAP Physician Scientist Program in Substance Abuse$1,133,676
K12 · FY2006 · DA · contact PI
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE$1,427,643
U10 · FY2005 · DA
AACAP Physician Scientist Program in Substance Abuse$906,837
K12 · FY2005 · DA
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE$400,000
U10 · FY2005 · DA
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE$1,500,000
U10 · FY2004 · DA
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE$1,230,205
U10 · FY2004 · DA
AACAP Physician Scientist Program in Substance Abuse$653,820
K12 · FY2004 · DA
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION$459,598
R01 · FY2004 · DA
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE$1,500,000
U10 · FY2003 · DA
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION$657,478
R01 · FY2003 · DA
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE$100,000
U10 · FY2003 · DA
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE$1,800,000
U10 · FY2002 · DA
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION$558,173
R01 · FY2002 · DA
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE$350,000
U10 · FY2002 · DA
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION$81,706
R01 · FY2002 · DA
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION$62,036
R01 · FY2002 · DA
ROCKY MOUNTAIN REGIONAL CLINICAL TRIALS NODE$2,200,000
U10 · FY2001 · DA
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION$543,852
R01 · FY2001 · DA
SUBSTANCE DEPENDENT TEENS--IMPACT OF TREATING DEPRESSION$532,588
R01 · FY2000 · DA